Orthofix Medical Inc. (OFIX) — SEC Financial Statements & Analysis

Orthofix Medical Inc. (OFIX) is a surgical & medical instruments & apparatus company. Orthofix Medical Inc. trades on Nasdaq as: OFIX. Orthofix Medical Inc. (OFIX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-05. Based on that filing, Orthofix Medical Inc. carries a market cap of $373.88M, a P/E ratio of -6.06x, a P/B ratio of 0.87x, a P/S ratio of 0.45x, an enterprise value of $491.79M, and an EV/EBITDA multiple of -12.57x. On profitability, it posts a gross margin of 71.31%, an operating margin of -4.70%, a net margin of -7.41%, a Return on Equity (ROE) of -13.91%, a Return on Assets (ROA) of -7.22%, and a Return on Invested Capital (ROIC) of -6.92%. Per share, it reports EPS of $-1.51, diluted EPS of $-1.51, free cash flow per share of $-0.68, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 2.99% year-over-year, net income growth of -50.11% year-over-year, and EPS growth of -51.82% year-over-year. On the balance sheet, it maintains a current ratio of 2.84x, a quick ratio of 1.53x, working capital of $289.12M, a debt-to-equity ratio of 1.03x, a debt ratio of 0.51, an interest coverage ratio of -1.88x, free cash flow of $-27.82M (TTM), and net debt of $117.91M. Figures sourced from SEC EDGAR.

Market Cap

$373.88M

P/E TTM

-6.06x

EPS TTM

$-1.51

P/B TTM

0.87x

ROE TTM

-13.91%

ROA TTM

-7.22%

Debt To Equity

1.03x

Free Cash Flow TTM

$-27.82M

Net Revenue TTM Growth 1Y

2.99%

Data as of 2026-06-30 · Source: SEC EDGAR